Friday 6 November 2026
Export FOCL’s income statement to Excel — free account
FocalTherics
FOCL Healthcare Medical Distribution
- Revenue
- +38.9%
- EPS
- −129.4%
- Free cash flow
- +21.5%
- Total debt
- +366.8%
Quarter to June 2026, against a year earlier
4.17
0.17
−3.92%
Follow FOCL
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (133.48%) | (83.79%) | (61.02%) | 0.00% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
4 | 3 | 3 | 4 | |
| (50.28%) | (40.37%) | (34.73%) | (27.10%) | ||
ROIC |
(110.75%) | (81.16%) | (71.99%) | (64.11%) | |
Return on Tangible Assets |
(126.51%) | (133.93%) | (101.51%) | (80.56%) | |
Average Days of Receivables |
50.27 | 100.17 | 84.02 | 131.89 | |
Free Cash Flow per Share |
(0.51) | (0.56) | (0.62) | (0.48) | |
Free Cash Flow |
(19.13) | (20.87) | (23.19) | (17.79) | |
Capital Expenditures |
(6.10) | (6.83) | (6.78) | (3.75) | |
| Other line items | |||||
Cash ROIC |
(32.75%) | (41.86%) | (37.19%) | (37.95%) | |
Accounts Receivable Turnover |
4.78 | 3.92 | 3.78 | 3.06 | |
Accounts Payable Turnover |
2.68 | 2.68 | 3.55 | 1.68 | |
Inventory Turnover |
3.25 | 2.56 | 3.00 | 1.73 | |
Average Days of Payables |
87.55 | 109.15 | 87.92 | 211.03 | |
Days of Inventory on Hand |
69.82 | 116.09 | 69.98 | 172.90 | |
Tax Rate |
0.01 | 0.01 | 0.02 | 0.01 | |
Research and Development Expense of Revenue |
12.47% | 13.06% | 13.70% | 15.06% | |
Selling, General and Administrative Expense of Revenue |
66.98% | 65.11% | 63.85% | 66.26% | |
Share Based Compensation of Revenue |
5.43% | 5.01% | 9.87% | 0.00% | |
Operating CF/Net income |
0.33 | 0.45 | 0.56 | 0.65 | |
Depreciation/Fixed assets |
0.71 | 0.58 | 0.89 | 0.00 | |
Capex/Depreciation |
(0.99) | (1.16) | (0.87) | 0.00 | |
Revenue per Share |
2.07 | 1.98 | 1.88 | 1.65 | |
Operating CF per Share |
(0.35) | (0.37) | (0.44) | (0.37) | |
Capex per Share |
(0.16) | (0.18) | (0.18) | (0.10) | |
Capex to Sales |
0.08 | 0.09 | 0.10 | 0.06 |
Columns are period end dates · fundamentals updated 26 Oct 2026